Codoxo, the leading provider of AI and generative AI-powered healthcare payment integrity solutions, has successfully raised $35 million in a oversubscribed Series C funding round led by CVS Health Ventures. Echo Health Ventures joined as a new investor, while existing backers—including Sands Capital, 111 West Capital, Brewer Lane Ventures, Wipro Ventures, 450 Ventures (the venture arm of Blue Cross and Blue Shield of Alabama), and QED Investors—continued their support. The funding will accelerate Codoxo’s mission to transform payment integrity across America’s largest health plans by leveraging advanced artificial intelligence to identify and prevent overpayments, reduce claim denials, and improve financial accuracy in healthcare billing. With generative AI at its core, Codoxo’s platform enables health plans to analyze complex claims data at scale, detect anomalies in real time, and deliver actionable insights that drive cost savings and operational efficiency. The investment underscores growing confidence in Codoxo’s technology and its ability to address one of the most pressing challenges in healthcare: revenue leakage due to inaccurate or fraudulent payments. According to industry estimates, billions of dollars are lost annually due to payment errors in the U.S. healthcare system, making solutions like Codoxo’s increasingly vital. The company’s expansion will focus on enhancing its AI models, expanding its customer base among national health plans, and strengthening its go-to-market strategy. With this new capital, Codoxo is also expected to deepen strategic partnerships and invest in talent to support its rapid growth. The round marks a significant milestone in Codoxo’s journey, positioning the company as a key player in the future of intelligent healthcare finance.